Direxion Daily S&P Biotech Bull 3x Shares Rating $91.18 -3.42 (-3.62%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$90.75 -0.43 (-0.47%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.77Holdings in LABU have an aggregate rating of Moderate Buy based on 666 analyst ratings issued in the past year covering 40 companies (44.3% of the portfolio).LABU Aggregate Price Target$91.18High Prediction$91.18Average Prediction$91.18Low Prediction$91.18Holdings in LABU have an aggregate price target of $91.18 and a range of $91.18 to $91.18 covering 40 companies (44.3% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.75%NBIXNeurocrine Biosciences$120.69+3.9%4.9754 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst Revision1.65%ABBVAbbVie$202.03+0.6%4.6474 of 5 stars2.88$208.35 3.1%24Dividend AnnouncementAnalyst RevisionPositive News1.63%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4532 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade1.62%AMGNAmgen$303.01+1.7%4.4673 of 5 stars2.46$314.09 3.7%24Insider TradePositive News1.62%INSMInsmed$81.06-3.0%4.0624 of 5 stars3.00$91.00 12.3%15Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.58%GILDGilead Sciences$109.95-0.1%4.7824 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News1.56%NTRANatera$162.31-3.5%2.5827 of 5 stars3.00$170.94 5.3%16Positive News1.54%INCYIncyte$72.05+0.9%4.5337 of 5 stars2.35$75.59 4.9%201.53%VRTXVertex Pharmaceuticals$484.24+0.8%4.1169 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News1.46%PCVXVaxcyte$79.74-3.3%2.5871 of 5 stars3.00$127.71 60.2%8Insider TradePositive News1.45%UTHRUnited Therapeutics$361.10-1.7%4.3542 of 5 stars2.67$388.25 7.5%12Insider Trade1.45%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9201 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.39%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7692 of 5 stars2.76$973.13 39.0%25Dividend Announcement1.39%HALOHalozyme Therapeutics$57.75+0.5%4.4546 of 5 stars2.60$62.78 8.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.35%BIIBBiogen$140.64+2.6%4.7469 of 5 stars2.43$211.85 50.6%30Analyst Forecast1.33%SRPTSarepta Therapeutics$106.28-2.0%4.4983 of 5 stars2.87$176.77 66.3%23Upcoming Earnings1.28%EXASExact Sciences$49.26-0.5%4.6912 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.23%TGTXTG Therapeutics$30.88-0.2%4.483 of 5 stars2.83$40.67 31.7%6Positive News1.21%MDGLMadrigal Pharmaceuticals$336.23-4.2%3.3205 of 5 stars2.69$351.67 4.6%131.17%MRNAModerna$35.53+5.3%4.7353 of 5 stars2.04$60.63 70.6%23Analyst DowngradeOptions Volume1.08%BPMCBlueprint Medicines$92.25-2.2%3.0033 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade0.96%ADMAADMA Biologics$15.84-1.5%3.5436 of 5 stars3.25$21.25 34.2%40.95%VKTXViking Therapeutics$34.07+7.7%4.3852 of 5 stars3.00$97.29 185.5%15High Trading Volume0.91%BBIOBridgeBio Pharma$36.85+0.1%4.7202 of 5 stars2.92$51.67 40.2%13Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up0.86%IONSIonis Pharmaceuticals$32.33-1.1%4.4271 of 5 stars2.70$60.00 85.6%20Earnings ReportAnalyst ForecastNews Coverage0.86%ROIVRoivant Sciences$10.68-0.4%2.7497 of 5 stars3.00$18.08 69.3%7Insider Trade0.85%CYTKCytokinetics$50.26-1.7%4.1939 of 5 stars2.94$82.00 63.2%18News Coverage0.83%RVMDRevolution Medicines$41.34-2.2%4.5121 of 5 stars3.08$66.25 60.3%120.81%APLSApellis Pharmaceuticals$27.52-2.9%4.2246 of 5 stars2.63$46.71 69.7%19Short Interest ↓0.79%EXELExelixis$36.85+5.0%4.6332 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider Trade0.75%CRSPCRISPR Therapeutics$47.91-5.0%3.1691 of 5 stars2.50$74.40 55.3%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision0.73%ALKSAlkermes$35.33-0.5%3.6708 of 5 stars2.82$38.36 8.6%110.71%SMMTSummit Therapeutics$22.12-4.1%2.3147 of 5 stars2.86$33.57 51.8%7Gap Up0.69%RNAAvidity Biosciences$31.12-4.3%1.613 of 5 stars3.00$65.80 111.4%100.58%BHVNBiohaven$36.90-7.2%3.4054 of 5 stars3.07$63.15 71.1%15Short Interest ↓Positive News0.57%NUVLNuvalent$79.49-3.5%2.1318 of 5 stars2.86$112.36 41.4%14Upcoming EarningsInsider Trade0.56%TWSTTwist Bioscience$41.31-8.4%4.606 of 5 stars2.70$53.80 30.2%10Positive News0.54%ACLXArcellx$63.75-2.8%2.0222 of 5 stars3.13$105.93 66.2%15Upcoming Earnings0.54%SWTXSpringWorks Therapeutics$58.29-2.7%1.246 of 5 stars3.00$71.50 22.7%6Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage0.51%RAREUltragenyx Pharmaceutical$42.59-4.2%4.6122 of 5 stars2.93$93.50 119.5%14Analyst Forecast This page (NYSEARCA:LABU) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
